Payment overview · 2025
General Payments
$63.07
2 reported records · 2 companies
Healthcare provider profile · identity verified
Tricia Chan, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BRONX, NY · NPI 1326131616
Verified facts
What the public records show
CMS Open Payments records show Tricia Chan, MD received $63.07 in general payments during 2025 across 2 reported records.
Takeda Pharmaceuticals U.S.A., Inc. accounted for 62.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $39.59 | 62.8% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $23.48 | 37.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $63.07 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GLASSIA Normalized: glassia |
Biological | Takeda Pharmaceuticals U.S.A., Inc. | $39.59 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $23.48 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1123 | 355 |
| Amlodipine Besylate | Amlodipine Besylate | 703 | 190 |
| Metformin Hcl | Metformin Hcl | 680 | 196 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 675 | 135 |
| Hydrochlorothiazide | Hydrochlorothiazide | 606 | 166 |
| Nifedipine Er | Nifedipine | 427 | 123 |
| Gabapentin | Gabapentin | 404 | 87 |
| Simvastatin | Simvastatin | 373 | 110 |
| Lisinopril | Lisinopril | 357 | 106 |
| Enalapril Maleate | Enalapril Maleate | 338 | 83 |
| Omeprazole | Omeprazole | 322 | 75 |
| Metoprolol Tartrate | Metoprolol Tartrate | 310 | 82 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 291 | 91 |
| Famotidine | Famotidine | 289 | 63 |
| Losartan Potassium | Losartan Potassium | 284 | 85 |
| Fluticasone Propionate | Fluticasone Propionate | 279 | 70 |
| Januvia | Sitagliptin Phosphate | 228 | 48 |
| Alendronate Sodium | Alendronate Sodium | 218 | 47 |
| Ezetimibe | Ezetimibe | 217 | 51 |
| Metoprolol Succinate | Metoprolol Succinate | 209 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 190 | 54 |
| Trazodone Hcl | Trazodone Hcl | 166 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 159 | 30 |
| Pioglitazone Hcl | Pioglitazone Hcl | 155 | 38 |
| Montelukast Sodium | Montelukast Sodium | 145 | 42 |
| Meclizine Hcl | Meclizine Hcl | 142 | 29 |
| Single Use Swab | Alcohol Antiseptic Pads | 132 | 46 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 128 | 36 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 122 | 41 |
| Hydralazine Hcl | Hydralazine Hcl | 121 | 36 |
| Breo Ellipta | Fluticasone/Vilanterol | 111 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 111 | 33 |
| Carvedilol | Carvedilol | 108 | 35 |
| Diclofenac Sodium | Diclofenac Sodium | 102 | 33 |
| Atenolol | Atenolol | 94 | 24 |
| Mirtazapine | Mirtazapine | 93 | 17 |
| Chlorthalidone | Chlorthalidone | 85 | 24 |
| Tradjenta | Linagliptin | 84 | 19 |
| Jardiance | Empagliflozin | 83 | 22 |
| Ozempic | Semaglutide | 80 | 17 |
| Furosemide | Furosemide | 79 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 79 | 27 |
| Eliquis | Apixaban | 76 | 22 |
| Sertraline Hcl | Sertraline Hcl | 74 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 67 | 11 |
| Donepezil Hcl | Donepezil Hcl | 65 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 63 | 21 |
| Incruse Ellipta | Umeclidinium Bromide | 56 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 19 |
| Memantine Hcl | Memantine Hcl | 52 | 15 |
| Valacyclovir | Valacyclovir Hcl | 49 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 46 | suppressed |
| Allopurinol | Allopurinol | 45 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 42 | suppressed |
| Folic Acid | Folic Acid | 41 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 39 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 38 | 11 |
| Metformin Hcl Er | Metformin Hcl | 38 | 13 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 37 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 35 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Spironolactone | Spironolactone | 34 | suppressed |
| Nitroglycerin | Nitroglycerin | 33 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 29 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Trulicity | Dulaglutide | 27 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 27 | 11 |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | 11 |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 20 | suppressed |
| Procto-Med Hc | Hydrocortisone | 20 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| True Comfort Pro Alcohol Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 12 |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 15 | 11 |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Prednisone | Prednisone | 15 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | 13 |
| Lovastatin | Lovastatin | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 12 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 12 | suppressed |
| Flovent Hfa | Fluticasone Propionate | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 11 | 11 |
| Epinephrine | Epinephrine | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $63.07 · 2 records | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA, ZENPEP | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error